
Loading, please wait...

Loading, please wait...

The recent advancement in nanofluidic biosensing technology offers a new path for medical diagnostics. Researchers developed ionic transistors using single sub-10 nm nanopores. These devices consist of van der Waals (vdW) heterostructures. Notably, they feature internal gate electrodes made of few-layer graphene. This design allows for precise control of ionic transport at very low voltages. Consequently, these tools may soon revolutionize how we monitor biological signals.
Traditional nanofluidic devices often require gate voltages exceeding 1V. However, the new vdW nanopores operate effectively at just 0.3V. This low-power requirement is critical for portable medical devices. Furthermore, these transistors function at near-physiological salt concentrations. Most previous models only worked in sub-millimolar environments. Therefore, this breakthrough bridges the gap between laboratory physics and clinical application. Importantly, it allows the device to interact directly with human fluids like blood.
The devices utilize negatively charged hexagonal boron nitride (hBN) walls. These walls dominate transport at salt levels below 100 mM. Specifically, a negative gate voltage enriches ion concentrations to enhance current. In contrast, a positive voltage creates a depletion zone. This zone suppresses ionic transport effectively. Additionally, the researchers used molecular dynamics simulations to study water behavior. They found that surface charges suppress the permittivity of interfacial water. This knowledge helps engineers sculpt local potential. Therefore, it enhances the sensitivity of future sensors.
This technology addresses a key need in modern medicine. Low-power ionic circuits can power implantable biosensors. Moreover, the ability to rectify ion current allows for more complex logic operations within the body. Scientists can now design sensors that respond to specific molecular cues. This could lead to real-time monitoring of electrolytes or hormones. Ultimately, this nanofluidic biosensing technology provides the foundation for biocompatible electronic interfaces.
Van der Waals nanopores use atom-thin materials like graphene and hBN. This structure allows for an internal gate electrode. Consequently, the device can control ion flow at much lower voltages than standard solid-state pores.
Medical samples like blood or interstitial fluid have high salt concentrations. Most electronic biosensors fail in these environments. This new nanofluidic biosensing technology maintains its function at 100 mM KCl, making it biocompatible.
The transistors operate at gate voltages as low as 0.3V. This significantly reduces energy consumption compared to previous 1V models. Therefore, it is ideal for battery-operated or self-powered diagnostic tools.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or endorse specific diagnostic products. Refer to the latest local and national guidelines for clinical practice.
References
Barajas-Aguilar AH et al. Electrostatic Gating of Ionic Conductance through Heterogeneous van der Waals Nanopores. ACS Nano. 2026 Jun 12. doi: 10.1021/acsnano.6c03174. PMID: 42284080.
"
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Researchers have developed nanofluidic ionic transistors using van der Waals heterostructures. These devices operate at near-physiological salt concentrations with low gate voltages. This advancement in nanofluidic biosensing technology paves the way for low-power, biocompatible diagnostic tools.
4 months ago

Novel diimide and hydrazone scaffolds, particularly compound #C4, synergistically reactivate latent HIV-1 when combined with JQ1 or PKC activators. Demonstrating donor-matched proviral transcription ex vivo and non-canonical signaling, these findings advance shock and kill strategies toward reservoir eradication.
Today

A cross-sectional study reveals that maternal RSV vaccination coverage reached only 43.7% in Argentina, with maternal vaccine knowledge being the sole independent predictor of uptake. Clinicians play a crucial role in eliminating informational and structural barriers to optimize infant health.
Today

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Yesterday

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Yesterday

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Yesterday